Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-032873
Filing Date
2015-02-04
Accepted
2015-02-04 10:09:30
Documents
11
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q d845963d10q.htm 10-Q 432123
2 EX-10.1 d845963dex101.htm EX-10.1 75904
3 EX-31.1 d845963dex311.htm EX-31.1 8596
4 EX-31.2 d845963dex312.htm EX-31.2 8864
5 EX-32.1 d845963dex321.htm EX-32.1 3824
  Complete submission text file 0001193125-15-032873.txt   4984856

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mygn-20141231.xml EX-101.INS 689936
7 XBRL TAXONOMY EXTENSION SCHEMA mygn-20141231.xsd EX-101.SCH 42409
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mygn-20141231_cal.xml EX-101.CAL 80942
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mygn-20141231_def.xml EX-101.DEF 266663
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20141231_lab.xml EX-101.LAB 357197
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20141231_pre.xml EX-101.PRE 314775
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 15573862
SIC: 2835 In Vitro & In Vivo Diagnostic Substances